This month brought several developments that shaped India's pharma industry, from new partnerships and licensing agreements to R&D expansion and international market opportunities
Regulatory actions from the USFDA and Maharashtra FDA dominated pharma news today. Companies secured key product approvals while others faced inspection findings and enforcement steps
The WHO science council has been renewed with 21 scientists and experts to help guide the future of global health. The World Health Organization announced the new membership.
The biggest pharma stories this week covered drug approvals, vaccines, medical devices, wellness investments, and emerging health research. These pharma stories also showed how quickly healthcare priorities are changing across India and global...
Drug development could see a major shift as Huawei expands its artificial intelligence partnerships with pharmaceutical companies
FDA approval of updated COVID vaccines now lets manufacturers ship doses that target the XFG variant for the respiratory virus season
This article will explore pharma marketing KPIs that Indian companies should track, how marketing KPIs differ from sales KPIs, which metrics managers should monitor monthly, and how to measure pharma marketing ROI in India
Recent regulatory decisions show companies expanding access to innovative medicines while pursuing new markets and indications
Piramal Alternatives has invested Rs 215 crore in Kolors Healthcare as India’s wellness market sees rising demand for preventive and personalized healthcare. The investment will support Kolors’ expansion, infrastructure upgrades...
The US weight-loss drug market faces a new affordability challenge as employers reconsider coverage for GLP-1 medicines amid rising healthcare costs
.jpg)
, CDSCO.jpg)
